Order Article Reprints

Dusabimana A, Siewe Fodjo JN, Ndahura MM, Mmbando BP, Jada SR, Boven A, De Smet E, Ukety T, Njamnshi AK, Laudisoit A, et al. Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281. Pathogens. 2022; 11(7):746. https://doi.org/10.3390/pathogens11070746

Dusabimana, Alfred, Joseph Nelson Siewe Fodjo, Michel Mandro Ndahura, Bruno P. Mmbando, Stephen Raimon Jada, Annelies Boven, Eric De Smet, Tony Ukety, Alfred K. Njamnshi, Anne Laudisoit, and et al. 2022. "Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281" Pathogens 11, no. 7: 746. https://doi.org/10.3390/pathogens11070746

Dusabimana, A., Siewe Fodjo, J. N., Ndahura, M. M., Mmbando, B. P., Jada, S. R., Boven, A., De Smet, E., Ukety, T., Njamnshi, A. K., Laudisoit, A., Abrams, S., & Colebunders, R. (2022). Correction: Dusabimana et al. Surveillance for Onchocerciasis-Associated Epilepsy and Ov16 IgG4 Testing of Children 6–10 Years Old Should Be Used to Identify Areas Where Onchocerciasis Elimination Programs Need Strengthening. Pathogens 2022, 11, 281. Pathogens, 11(7), 746. https://doi.org/10.3390/pathogens11070746